BF-200 ALA for the Photodynamic Treatment of Non-Aggressive Basal Cell Carcinoma: Results of a Phase III Comparator Trial. (2017). SKIN The Journal of Cutaneous Medicine, 1(3.1), s112. https://doi.org/10.25251/skin.1.supp.111